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REVIEW
Abstract—: Pressure ulcers are a highly prevalent source
of morbidity with an equally high incidence of up to 38.0%
amongst different categories of healthcare institutions. There-
fore, the management and therapeutic approach toward these
often hospital- or facility-acquired problems remain critical
aspects of long-term care. Negative pressure wound therapy
(NPWT) has proven effective in addressing the barriers to pres-
sure ulcer healing including increasing blood flow to previously
ischemic wound areas by generating subatmospheric pressure
which vacuums in circulation. The objective of this study was
to compare negative pressure wound therapy (NPWT) versus
surgical wounds healing by secondary intention (SWHSI). A
systematic literature search was conducted using the PubMed
and Scopus search engine up until the 20 Th January 2017
including the terms: “negative pressure wound therapy” and
“pressure ulcers”. In this systematic review, six randomized
controlled trials were included. NPWT is deemed appropriate
and effective method and widely used by clinicians to promote
the healing of wounds and ulcers of different etiology. The
heterogeneity found in individual trials regarding the inclusion
criteria, therapeutic procedures, the criteria and methods of
outcome evaluation, however, did not allow for a data evaluation
with statistically valid conclusions. It is reasonable to assume
that a subset of patients with pressure ulcers can be effectively
treated with NPWT, with optimal results and good cost-benefit
ratio, also with respect to the quality of life.
Keywords—NPWT, VAC, Negative pressure wound therapy
I. INTRODUCTION
PRESSURE ulcers are a significant source of morbiditywith an equally high incidence of up to 38.0% amongst
different categories of healthcare institutions.1, 2 In particular
this condition affects people aged over 65 years with a
prevalence ranging from 0.3% to 46% and an incidence
ranging from 0.8% to 34%.3 Therefore, the management and
therapeutic approach toward these often hospital- or facility-
acquired problems remain critical aspects of long-term care.4
Often, complexities exist structurally within these wounds
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including undermining, tunneling, and sinus tract formation
along with exudate and necrotic tissue.5 These serve as
barriers to healing as they may host resident and occult
sources of foreign bodies as well as unreachable nonviable
material, both of which may promote ischemia, inflamma-
tory responses, and an increased susceptibility to pathogenic
invasion.6–10 Pressure ulcers and their complications, such as
infection and sepsis, especially when hospital-acquired, can
raise medico-legal issues. Therefore, an accurate planning of
the best therapeutic options for the patient is essential. Neg-
ative pressure wound therapy (NPWT) has proven effective
in addressing the barriers to pressure ulcer healing including
increasing blood flow to previously ischemic wound areas
by generating subatmospheric pressure.6 By suctioning the
pro-inflammatory cytokines and enzymes are furthermore
decreased,7, 8 while favorable healing factors such as the
infiltration of vascular endothelial growth factor (VEGF) and
chemotaxis of fibroblasts increase angiogenesis.9, 10 Due to
the mechanical washout of the wound bed, the pathogenic
load is decreased thus indirectly lowering the toxic burden
on the pressure wound.6
II. METHODS
A. Objectives
The objective of this study was to compare negative
pressure wound therapy (NPWT) versus surgical wounds
healing by secondary intention (SWHSI).
B. Types of studies
Randomized controlled trials (RCTs) were identified
through a systematic review of published literature (full
article, thesis, or abstract).
C. Types of participants
Patients presenting with pressure ulcers in any location.
D. Types of interventions
The types of interventions were NPWT in experimental
group versus SWHSI in control group (surgical debridement,
enzyme or chemical necrosectomy) Types of outcome mea-
sures The primary outcomes of interest were summarized
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in efficacy (healed of ulcer, reduction of ulcer volume,
local improvement in ulcer characteristics), the secondary
outcomes in the socio-economic advantages (consumption of
health resources).
E. Studies selection
A systematic literature search in accordance with the
Preferred Reporting Items for Systematic Reviews and Meta-
analyses (PRISMA) standards,11 was conducted using the
PubMed and Scopus search engine up until the 20 Th
January 2017 including the terms: “negative pressure wound
therapy” and “pressure ulcers”. No language, publication
date, restrictions were imposed. All titles and abstracts of the
considered studies were analysed to select only the studies
that reported the PICO (P = Patient, Population or Problem;
I = Intervention; C = Comparison; O = Outcome).12 When
multiple articles were published from a single study group
and overlapping study periods were reported, only the most
recent article was considered so as to avoid duplication of
data. The Pubmed function “related articles” was used to
enlarge each search, and the reference list of all potentially
eligible studies was analysed. To minimize retrieval bias,
a manual search method including the Science Citation
Index Expanded, Scopus and Google Scholar databases was
performed. After this initial process, the full-text papers were
independently screened by 2 authors for eligibility. The final
decision on eligibility was reached by consensus between the
2 screening authors. Data were extracted by 2 authors based
on an intention-to-treat principle. Any disagreement was
resolved through discussion with a reassessment of the data
and/or by involving a third author. The methodological qual-
ity assessment of the included studies was evaluated with the
instructions and the items given in the Cochrane Handbook
for Systematic Reviews of Interventions (sequence generation
and allocation concealment for selection bias, blinding of
participants or personnel for performance bias, blinding of
outcome assessors for detection bias, incomplete outcome
data for attrition bias and selective reporting bias)13–16 A
protocol for this meta-analysis has been registered on PROS-
PERO database (ID: CRD42017059678).
III. RESULTS
The PRISMA flow diagram for systematic reviews is
presented in (Fig. 1). We identified 76 publications using the
literature search strategy described above. After excluding
63 records following the review of the titles and abstracts,
13 abstracts eligible for full-text evaluation remained. After
full-text assessment, we excluded 7 studied17–23 (Tab. I) and
identified 6 publications that fulfilled the inclusion criteria
which reported data about pressure ulcers (Tab. II).24–29
Quality assessment of the included studies. Since all the
included studies are RCTs the quality assessment was based
on the risk of bias. Overall risk of bias of the included studies
was low as reported in table 3.(Tab. III) In the pressure
ulcers analysis, the stage of ulcers was reported in all trials
and it was the same (III and IV stage). In three studies the
authors described the etiology of immobilization and reported
a traumatic paraplegia. The location of ulcer was reported
in five studies and it was exclusively sacral in the paper
of Dwivedi24 and Wild,27 differently Ashby25 and Ford29
reported a mix of locations: sacral, ischial, lateral malleolar
and trochanter region. Overall, 141 patients were enrolled: 62
underwent NPWT and 79 other conventional treatments. All
the included trials reported different types of outcomes, so the
reported outcomes were not comparable. The analyzed out-
comes are extremely numerous and are categorized in some
different groups: ulcer healing, reduction of ulcer volume,
local improvement in ulcer characteristics and consumption
of health resources. Only two trials evaluated ulcer healing:
Ashby25 and de Laat.26 In the first study only one pressure
ulcer (16.6%) which underwent NPWT (79 days) healed; in
the other study the authors performed a subgroup analysis
of patients with pressure ulcers, but they did not describe
the results and reported only the conclusion (“statistically
significantly faster wound healing in the topical negative
pressure group”)20 (Tab. IV).
Three trials described the reduction in ulcer volume, but
the outcome descriptions were very inconsistent [24,28,29].
Dwivedi reported the length and width of ulcer,24 differently
Wanner reported the mean (SD) time to reach 50% of
the initial volume28 and Ford reported the mean percent
reduction in ulcer volume.29 In the first study the length
and width of an ulcer decreased significantly (p<0.01) in
NPWT group compared to standard care group at week
9.24 In the other two studies the authors did not report a
significant difference between the two groups, respectively
in Wanner 27 days in NPWT group and 28 in the traditional
treatment and 51.8% with NPWT in Ford and 42.1% with tra-
ditional treatment28, 29 (Tab. IV) . The authors’ choice of the
characteristics for the local evaluation of ulcer improvement
was very heterogeneous. These characteristics were macro-
scopically evaluated through a biopsy with a histologically
examination. In the macroscopic examination, the presence
of the granulation tissue was the most important favorable
prognostic sign. The evaluation of this tissue was performed
in different modalities: newly-formed granulation tissue and
wound contracture (measured the volume instead of the
area of the usually undermined wounds) as reported from
Wanner [28], the absolute and relative proportion of wound
surface granulation tissue as reported from Wild27 or the
conversion of slough into red granulation tissue as reported
from Dwivedi.24 Conversely the presence of exudates, fibrin
or necrosis were poor prognostic signs: absolute and relative
proportion of fibrin tissue at the wound base or absolute and
relative proportion of necrosis. Only few significantly better
results were reported in patients who underwent NPWT
(lower exudates in NPWT group at weeks 4 and 9 and higher
conversion of slough into red granulation tissue, increase
in surface granulation), differently the other evaluation did
not report report any advantage in macroscopic (newly-
formed granulation tissue and wound contracture, absolute
and relative proportion of fibrin tissue at the wound base
and of necrosis) or biopsy evaluation (mean number of PMNs
and lymphocytes per high-power field and mean number of
capillaries per high-power field). (Tab. IV) The analysis of
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Figure 1. PRISMA flow diagram of the analyzed papers
costs was evaluated only from Wanner, that did not report any
data but only the conclusion about NPWT “cheaper than the
traditional dressings”,28 other studies reported the indirect
costs as the discharge from hospital, the mean number of
treatment visits per week or the median number of dressing
changes per day. Dwivedi reported that the hospital stay was
significantly lower (p=0.001) in NPWT at week 2.24 Ashby
reported a lower mean number of treatment visits per week
in patients who underwent NPWT (3 vs 6),25 whereas Wild
reported only that lower dressing changes resulted in patients
who underwent NPWT27 (Tab. IV). The quality of life was
evaluated only from Wanner and it was better in patients
underwent NPWT, but without reporting of any data.28 In the
surgical wounds healing by secondary intention (SWHSI) all
the studies described the type of procedure performed and
the locations of the incision.
IV. DISCUSSION
The wound healing is a complex regenerative process with
multifactorial determination. Despite the recent advance in
medicine the patients with various pressure ulcers still rep-
resent a major concern due to lack of an effective treatment.
Moreover, in the light of the modern laparoscopic surgery
and a strive to diminish hospital costs these patients are
not “desirable” because of the significant burden on the
nursing staff, prolonged hospital stay, expensive treatment
and unsatisfactory results. The total cost in United Kingdom
is between 1.4 and 2.1 billion annually,4 which is confirmed
by a recent systematic review.30 Unfortunately, despite the
intensive research in this particular area, there are few RCTs
in the literature yet. The evidence-based analysis of Medical
Advisory Secretariat of Ontario Ministry of Health and Long-
Term Care published in 2009 concluded that “the role of
NPWT in chronic pressure ulcers remains unclear”.31 A
Cochrane based systematic review of RCTs of Dumville et
al. published in 2015, reported „no rigorous RCT evidence
available regarding the effects of NPWT compared with
alternatives for the treatment of pressure ulcers. High uncer-
tainty remains about the potential benefits or harms, or both,
of using this treatment for pressure ulcer management“.32
In this systematic review, six randomized controlled trials
were included.24–29 In the two groups the characteristics of
patients were similar, but the high heterogeneity regarding
interventions, comparisons and outcomes rendered the data
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Table I
EXCLUDED STUDIES
Author, year of publi-
cation
Reasons of exclusion
de Laat 2017 A cross-sectional survey self-management of pressure ulcer prevention in adult paraplegics.
Skrinjar 2016 In this randomized controlled trial the Authors analyzed , 60 consecutive patients with chronic leg wounds or surgical site infections
after revascularization of lower extremities and compared of Negative Pressure Wound Therapy additional polymeric membrane
interface dressing (PMD; PolyMem WIC) versus Negative Pressure Wound Therapy alone
Sáez-Martín 2015 In this randomized controlled trial the Authors analyzed ten patients with nonhealing ulcers and compared a novel biocompatible
polyurethane foam versus the conventional foam
Wagstaff 2014 In this randomized controlled trial the Authors analyzed twenty pressure ulcers and compared negative pressure and nanocrystalline
silver dressings versus negative pressure wound therapy alone
Tuncel 2013 In this randomized controlled trial the Authors analyzed 50 consecutive patients with wound and compared conventional antiseptic
(polyhexanide solution) dressings, versus saline-soaked antibacterial gauze-based negative pressure wound therapy
Dunn 2011 This prospective multi-center non-comparative study reported the use of gauze-based Negative Pressure Wound Therapy in 131
patients with in chronic and acute wounds
Kordestani 2008 In this randomized controlled trial the Authors analyzed eighty-five patients with diabetic foot ulcers, pressure ulcers or leg ulcers
and compared bioactive study dressing versus control dressing alone
Table II
CHARACTERISTICS OF THE INCLUDED STUDIES
Type of study Nation were
perfomed the trial
Etiology of immobi-
lization
Location of ulcers
and stage
Patients
underwent
NPWT
Patients
underwent
conventional
treatment
Dwivedi
2016
RCT India Traumatic paraplegia Sacral / III and IV
stage
21 23
Ashby 2012 RCT UK NR Heel, Trochanter,
Sacrum, Gluteal,
Ischial / III and IV
stage
6 6
De Laat
2011
RCT The Netherlands Traumatic paraplegia NR / IV stage 6 6
Wild 2008 RCT Austria NR Sacral / III and IV
stage
5 5
Wanner 2003 RCT Switzerland Traumatic paraplegia Sacral / III and IV
stage
11 11
Ford 2002 RCT USA NR Ischial, Sacral,
Lateral malleolar,
Trochanter and
Calcaneal / IV stage
20 21
not suitable to perform meta-analysis. All trials have agreed
that the pressure ulcers healed better in patients underwent
NPWT, but the data reported are very poor. Ashby showed
that only one pressure ulcer (17%) healed in NPWT group,25
whereas de Laat reported only a “statistically significantly
faster wound healing”.26 Different results were found in
the trials that described the reduction in ulcer volume with
different type of measure – length and width of ulcer,
mean (SD) time to reach 50% of the initial volume, mean
percent reduction in ulcer volume). In this outcome the
results are different: Dwivedi reported statistically significant
better results in patients underwent NPWT.24 In contrast,
Wanner28 and Ford29 did not find a significant difference
between the two groups. A small retrospective case series of
20 patients with various wounds (2 pressure ulcers) reported
mean reduction of wound area with 29% after treatment
with V.A.C. R© (KCI).33 The authors reported reduction of the
pressure ulcers size with 52 and 13 mm after 26 and 32 days
with NPWT, respectively. In a RCT (79% pressure ulcers)
Joseph et al. reported volume reduction in 78% in NPWT vs.
30% in the conventional group and 64% granulation tissue
proven histologically after 6-weeks treatment.34 Despite the
low evidence level several case reports showed reduction of
wound volume and complete healing in two months.35, 36
The same problem was encountered in the analysis of very
heterogeneous characteristics for the local evaluation of ulcer
improvement. One study showed only few significantly better
results in patients underwent NPWT (lower exudates in
NPWT group at weeks 4 and 9, higher conversion of slough
into red granulation tissue and an increase of the surface
granulation).24 Differently, the other evaluations reported no
advantage in macroscopic (newly-formed granulation tissue
and wound contracture, absolute and relative proportion of
fibrin tissue at the wound base and of necrosis)27, 28 and
biopsy evaluation (mean number of PMNs and lymphocytes
per high-power field and mean number of capillaries per
high-power field).29 In the most recent work from China
the authors compare conventional treatment with NPWT
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Table III
RISK OF BIAS. (YES E.G. LOW RISK OF BIAS; NO E.G. HIGH RISK OF BIAS)
Selection bias Performance bias Attrition bias Detection bias Reporting bias
Dwivedi 2016 Yes Yes Unknown Unknown Yes
Ashby 2012 Yes Yes Yes Yes Yes
De Laat 2011 Yes Yes Unknown No Yes
Wild 2008 Yes Yes Unknown Unknown unknown
Wanner 2003 Unknown Unknown Unknown Unknown Yes
Ford 2002 Yes Yes Unknown Yes Yes
Table IV
COMPARISON OF THE THERAPY OUTCOMES AFTER THE INTRODUCTION OF NPWT
Lesion reduction Outcomes
Ashby
2012
Only one pressure ulcer healed (NPWT group) during follow-up (time
to healing 79 days).
mean number of treatment visits per week: 3.1 (NPWT) and 5.7 (SC);
6/6 NPWT and 1/6 SC participants withdrew from their allocated trial
treatment.
De Laat
2011
statistically significantly faster wound healing in the topical negative
pressure group
Dwivedi
2016
Significantly (p<0.01) decreased in NPWT group as compared with
standard care group at week 9. At weeks 1, 2 and 3, depth was
significantly (p<0.05) higher in NPWT group, whereas at week 9 a
significant reduction (p=0.01) was observed
Secretion: Significantly (p=0.001) lower in NPWT group at weeks 4
and 9; Conversion of slough into red granulation tissue: Significantly
higher in NPWT group (p=0.001
Discharge from hospital (p=0.001) lower in NPWT at week 2
Wanner
2003
27 (10) days in the vacuum-assisted group and 28 (7) in the traditional
group
Newly-formed granulation tissue and wound contracture (measured the
volume instead of the area of the usually undermined wounds) equally
effective
NPWT cheaper than traditional dressings, QoL improved more
Ford
2002
42.1% with HP and 51.8% with VAC (p = 0.46) Mean number of PMNs and lymphocytes per high-power field: De-
creased in the VAC group and increased in the HP group
Mean number of capillaries per high-power field: The mean number
of capillaries per high-power field was greater in the VAC group
Improved biopsy-proven osteomyelitis underlying the ulcers: Improved
with VAC
Wild Increase in fibrin tissue at the wound base of 21.8%, whereas in the
V.A.C group, a 27% reduction was observed (P0.035)
Increase in surface granulation tissue of 54% was observed in the
V.A.C. group and a reduction in the Redon group (P0.001).
Necrosis insignificantly reduced in the V.A.C. group
and NPWT plus microplasma using the following outcome
measures – the maturity of granulations, growth degree of
epithelium, blood perfusion, density of new vessels, wound
area and total healing rate.37 The combination of NPWT
with microplasma yielded the best results followed by NPWT
alone and conventional treatment. The quality of life (QoL)
was evaluated in only one trial.38 The authors reported a bet-
ter quality in NPWT group, but without any data. Similarly,
in various acute or chronic wounds, others reported better
QoL.30, 39 In fact, a true cost analysis was not performed.
Wanner,28 wrote only that NPWT was “cheaper than the
traditional dressings”. In the other studies, reporting indirect
costs (discharge from hospital, the mean number of treatment
visits per week or the median number of dressing changes per
day), the authors showed better results in NPWT group.24, 25
In 2004 the German and Austrian Societies for Wound Heal-
ing and Wound Management stated that NPWT treatment
is cost effective.38 In a RCT with 65 cases Braakenburg
et al. reported similar overall costs.40 In 2008, Apelqvist
et al. reported significantly lower costs in NPWT group
vs. standard moist wound therapy of diabetic foot wounds
(with average 12 852 $).41 A systematic review of National
Health Service of UK supported the usage of NPWT in
chronic wound management due to better QoL and improved
cost effectiveness.39 The work encourages development of
national guideline for NPWT in wound management.
V. CONCLUSION
NPWT is deemed appropriate and effective method and
widely used by clinicians to promote the healing of wounds
and ulcers of various etiology. High quality clinical studies
are nevertheless few and do not allow to draw definitive
conclusions. The analysis of the selected trials showed an
overall favorable trend for NPWT compared to conventional
therapy, in particular in a wounds with low secretion and
presence of granulation tissue. This would seem to indicate
that the NPWT should not be used too early in pressure
ulcers. The heterogeneity found in individual trials regarding
the inclusion criteria, therapeutic procedures, the criteria and
methods of outcome evaluation, however, did not allow for
a data evaluation with statistically valid conclusions. The
outcome heterogeneity between studies suggests that NPWT
cannot be indiscriminately considered the standard treatment
for pressure ulcers. An adequate and detailed information
should be provided, in order to acquire a valid patient’s
consent to NPWT. In fact, considering the lack of an effective
treatment of pressure ulcers, the patient should be given an
appropriate range of choices, in order to express his consent
to undergo the best therapeutic option for the specific case. It
is reasonable to assume that a subset of patients with pressure
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ulcers can be effectively treated with NPWT, with optimal
results and good cost-benefit ratio, also with respect to the
quality of life41, 42 Further clinical studies are needed on
homogeneous groups of patients with homogeneous inclusion
criteria, therapeutic procedures and outcome measures. In our
opinion, it is mandatory to include patients with uniform
characteristics in the new Randomised Controlled Trials’
design: age, nutritional status, comorbidities, stage and size
of pressure ulcers. Furthermore, we suggest to report the fol-
lowing principal outcomes: treatments failure rate, complete
healing time, quality of life during treatment and wound care
cost.
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